(RTTNews) - Syndax Pharma (SNDX) revealed Loss for fourth quarter of -$68.01 million
The company's bottom line came in at -$68.01 million, or -$0.78 per share. This compares with -$94.17 million, or -$1.10 per share, last year.
The company's revenue for the period rose 794.9% to $68.73 million from $7.68 million last year.
Syndax Pharma earnings at a glance (GAAP) :
-Earnings: -$68.01 Mln. vs. -$94.17 Mln. last year. -EPS: -$0.78 vs. -$1.10 last year. -Revenue: $68.73 Mln vs. $7.68 Mln last year.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
